Filter Results
:
(49)
Show Results For
- All HBS Web (72)
- Faculty Publications (30)
Show Results For
- All HBS Web (72)
- Faculty Publications (30)
Sort by
- January 2001
- Case
Merck Global Health Initiatives (B): Botswana
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,...
View Details
Keywords:
Health Disorders;
Health Care and Treatment;
Private Sector;
Public Sector;
Alliances;
Problems and Challenges;
Africa;
Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (B): Botswana." Harvard Business School Case 301-089, January 2001.
- January 2001
- Case
Merck Global Health Initiatives (A)
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,...
View Details
Keywords:
Programs;
Philanthropy and Charitable Giving;
Health Disorders;
Health Care and Treatment;
Private Sector;
Public Sector;
Alliances;
Problems and Challenges;
Pharmaceutical Industry;
Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (A)." Harvard Business School Case 301-088, January 2001.
- October 2009 (Revised July 2013)
- Case
Gilead Sciences, Inc.: Access Program
By: V. Kasturi Rangan and Katharine Lee
Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients...
View Details
Keywords:
Health Care and Treatment;
Emerging Markets;
Product;
Sales;
Competitive Strategy;
Biotechnology Industry;
Pharmaceutical Industry
Rangan, V. Kasturi, and Katharine Lee. "Gilead Sciences, Inc.: Access Program." Harvard Business School Case 510-029, October 2009. (Revised July 2013.)
- 03 Mar 2009
- First Look
First Look: March 3, 2009
control over pricing and associated revenues from the content to the content provider in order to reduce price competition at the platform level. Download the paper: http://www.hbs.edu/research/pdf/08-009.pdf Applying the Care Delivery Value Chain: View Details
Keywords:
Martha Lagace
- 2024
- Working Paper
HIV Tests and AIDS Treatments—Containing a Fearsome Pandemic: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how a diverse cast of characters, including public health organizations, research laboratories, for-profit healthcare companies, activists, and regulators, rolled back the outbreak of HIV/AIDS in just fifteen years. Moreover, as the case...
View Details
Keywords:
Health Care and Treatment;
Technological Innovation;
Innovation Strategy;
Technology Adoption;
Collaborative Innovation and Invention;
Innovation and Invention;
Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "HIV Tests and AIDS Treatments—Containing a Fearsome Pandemic: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-007, July 2019. (Revised May 2024.)
- June 2004 (Revised May 2005)
- Case
World Vision International's AIDS Initiative: Challenging a Global Partnership
By: Christopher A. Bartlett and Daniel F. Curran
After 25 years of building a network of interdependent, national organizations delivering relief and development that are responsive to local needs, World Vision's International office is planning to implement a major global HIV/AIDS initiative that challenges the...
View Details
Keywords:
Change Management;
Decision Choices and Conditions;
Globalized Markets and Industries;
Governing and Advisory Boards;
Management Systems;
Networks;
Partners and Partnerships;
Welfare;
Adaptation
Bartlett, Christopher A., and Daniel F. Curran. "World Vision International's AIDS Initiative: Challenging a Global Partnership." Harvard Business School Case 304-105, June 2004. (Revised May 2005.)
- February 2011 (Revised August 2011)
- Case
Brazil: Leading the BRICs?
By: Arthur A. Daemmrich and Aldo Musacchio
Brazil's new president, Dilma Rousseff, had announced plans to sustain GDP growth above 5% annually and continue the country's leadership role among emerging economies. Between 2003 and 2010, Brazil benefited from strong economic growth and stable policies under the...
View Details
Keywords:
Developing Countries and Economies;
Intellectual Property;
Infrastructure;
Economic Growth;
Trade;
International Relations;
Economic Systems;
Globalization;
Corporate Strategy;
Brazil;
Russia;
India;
China;
United States
Daemmrich, Arthur A., and Aldo Musacchio. "Brazil: Leading the BRICs?" Harvard Business School Case 711-024, February 2011. (Revised August 2011.)
- September 21, 2013
- Other Article
Redefining Global Health-care Delivery
By: Jim Yong Kim, Paul E. Farmer and Michael E. Porter
Initiatives to address the unmet needs of those facing both poverty and serious illness have expanded significantly over the past decade. But many of them are designed in an ad-hoc manner to address one health problem among many; they are too rarely assessed; best...
View Details
Keywords:
Health
Kim, Jim Yong, Paul E. Farmer, and Michael E. Porter. "Redefining Global Health-care Delivery." Lancet 382, no. 9897 (September 21, 2013).
- March 2018 (Revised January 2019)
- Case
Gilead Mexico
By: Michael Chu and V. Kasturi Rangan
With a breakthrough cure for Hepatitis C listing in the U.S. at $1,000/pill, Gilead must now solve the issue of making it available to patients across the world, much as it did for its blockbuster HIV/AIDS antiretrovirals. For Erik Musalem, the new general manager of...
View Details
Chu, Michael, and V. Kasturi Rangan. "Gilead Mexico." Harvard Business School Case 318-111, March 2018. (Revised January 2019.)
- 2006
- Working Paper
Male Circumcision and AIDS: The Macroeconomic Impact of a Health Crisis
By: Amrita Ahuja, Brian Wendell and Eric D. Werker
Theories abound on the potential macroeconomic impact of AIDS in Africa, yet there have been surprisingly few empirical studies to test the mixed theoretical predictions. In this paper, we examine the impact of the AIDS epidemic on African nations through 2005 using...
View Details
Keywords:
Macroeconomics;
Health Disorders;
Welfare or Wellbeing;
Poverty;
Research;
Education;
Nutrition;
Risk Management;
Africa
Ahuja, Amrita, Brian Wendell, and Eric D. Werker. "Male Circumcision and AIDS: The Macroeconomic Impact of a Health Crisis." Harvard Business School Working Paper, No. 07-025, October 2006. (Revised March 2009.)
- Research Summary
Male Circumcision and HIV/AIDS: The Macroeconomic Effects of a Health Crises (with Eric Werker and Brian Wendell)
Theories abound on the possible impact of AIDS on economic growth and savings in Africa; yet there have been surprisingly few empirical studies to test the mixed theoretical predictions. In this paper, we examine the impact of the AIDS epidemic on African nations...
View Details
- April 2009 (Revised May 2010)
- Case
Partners In Health: HIV Care in Rwanda
By: Michael E. Porter, Scott S. Lee, Joseph Rhatigan and Jim Yong Kim
In 2005, Partners in Health (PIH) was invited by the Rwandan Ministry of Health to assume responsibility for the management of public health care in two rural districts in Eastern Rwanda and create an HIV treatment program at these sites. PIH successfully implemented a...
View Details
Keywords:
Developing Countries and Economies;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Service Delivery;
Nonprofit Organizations;
Expansion;
Health Industry;
Rwanda
Porter, Michael E., Scott S. Lee, Joseph Rhatigan, and Jim Yong Kim. "Partners In Health: HIV Care in Rwanda." Harvard Business School Case 709-474, April 2009. (Revised May 2010.)
- June 2022
- Article
A New Initiative to Track HIV Resource Allocation and Costs
By: Ryan McBain, AK Nandakumar, Michael Ruffner, Carlyn Mann, Mai Hijazi, Susanna Baker, Linden Morrison, Kalipso Chalkidou, Shufang Zhang, Iris Semini, Fern Terris-Prestholt, Steven Forsythe, Sarah Byakika, Joshua Musinguzi and Robert S. Kaplan
In early 2020, several global health institutions – including the Global Fund to Fight AIDS, Tuberculosis and Malaria; Joint United Nations Program on HIV/AIDS (UNAIDS); United States Agency for International Development; and Office of the Global AIDS Coordinator at...
View Details
Keywords:
Activity Based Costing;
HIV;
Cost;
Health Care;
Healthcare;
Health Care and Treatment;
Activity Based Costing and Management;
Resource Allocation;
Health Industry;
Africa
McBain, Ryan, AK Nandakumar, Michael Ruffner, Carlyn Mann, Mai Hijazi, Susanna Baker, Linden Morrison, Kalipso Chalkidou, Shufang Zhang, Iris Semini, Fern Terris-Prestholt, Steven Forsythe, Sarah Byakika, Joshua Musinguzi, and Robert S. Kaplan. "A New Initiative to Track HIV Resource Allocation and Costs." Bulletin of the World Health Organization 100, no. 6 (June 2022): 358–358A.
- 09 Apr 2018
- Sharpening Your Skills
The Dark Side of Performance Bonuses
field research studies what motivates hairdressers in Zambia to provide HIV/AIDS education in their salons. Is Group Loyalty a Force for Good or Evil? Many organizations try to foster employee loyalty, but at a risk. Researchers discover...
View Details
Keywords:
by Sean Silverthorne
- 22 Sep 2003
- Research & Ideas
How Businesses Can Respond to AIDS
nations, but the diseases' effects and potential impact on businesses and organizations is only recently coming into stark relief, particularly in Africa and Asia. Approximately 38 million adults and children in Africa and Asia (including Eastern Europe) were estimated...
View Details
Keywords:
by Martha Lagace
- 12 Dec 2022
- Research & Ideas
Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them
example that could inform change is in the successful representation of minorities in tests for novel HIV/AIDS drugs. Black patients make up roughly 30 percent of the patients taking part in clinical trials for these medicines, compared...
View Details
- 26 Sep 2006
- First Look
First Look: September 26, 2006
Jossey-Bass, 2007 (forthcoming) Abstract It is more than mere coincidence that the incidence of HIV/AIDS occurs in the world's poorest countries. Of the more than 40 million people currently living with HIV, 95 percent are in the...
View Details
Keywords:
Sean Silverthorne
- 15 Mar 2011
- First Look
First Look: March 15
China) in multilateral negotiations, notably in the World Trade Organization's Doha Round. Yet Brazil's actions to enforce a compulsory license of a patented therapy for HIV/AIDS and its victory in a longstanding WTO dispute with the...
View Details
Keywords:
Sean Silverthorne
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
application, the paper chip, which costs only pennies to produce, monitors liver function and the adverse side effects of the powerful drugs used to treat HIV/AIDS and TB. In February, DFA's reach broadened when the Gates Foundation...
View Details
- 15 Feb 2012
- Op-Ed
Occupy Wall Street Protestors Have a Point
unaffordable (which the pharmaceutical company Cipla did with HIV/AIDS drugs in Africa), and that brought housing to urban poor (one of building materials maker CEMEX's accomplishments in Mexico). Based on our research, we believe the...
View Details